![](https://investorshub.advfn.com/uicon/8777.png?cb=1703671008)
Thursday, January 26, 2017 9:16:05 AM
$ 11- $14 buys were not just retail IMO. The low volume walk down kept options prices low - see bottom of the page for options on 1/11 when the stock was at $13 and 1/3 when it was below $10.
Not looking to trade options, just studying their effect because HALO seems to be so highly controlled and my working theory is that the Big Boys want to end up with almost all the marbles here.
open high low close
01/24/17 11.64 11.815 11.14 11.61 982,255
01/23/17 11.50 12.05 11.38 11.59 2,130,086
01/20/17 11.10 11.54 10.965 11.50 2,006,398
01/19/17 11.26 11.30 10.81 11.08 1,044,029
01/18/17 10.93 11.29 10.74 11.27 1,517,555
01/17/17 11.22 11.3012 10.78 10.89 1,775,547
01/13/17 11.81 12.11 11.28 11.39 2,091,160
01/12/17 11.71 12.25 11.34 11.86 1,935,986
01/11/17 12.83 13.16 11.90 11.91 2,823,627
01/10/17 13.93 14.03 12.66 12.89 4,803,439
01/09/17 13.38 14.36 13.24 14.24 4,065,292
01/06/17 12.35 13.77 12.3001 13.38 9,144,242
01/05/17 11.79 12.79 11.385 12.61 16,924,410
01/04/17 10.02 10.79 9.98 10.69 1,607,231
01/03/17 10.09 10.23 9.68 9.99 1,032,900
12/30/16 9.95 10.14 9.81 9.88 805,487
12/29/16 9.92 9.9904 9.69 9.94 1,455,456
12/28/16 10.41 10.42 9.89 9.91 1,393,311
12/27/16 10.63 10.77 10.30 10.31 841,440
12/23/16 10.20 10.60 10.1362 10.56 949,066
12/22/16 10.85 10.85 10.15 10.22 1,056,267
12/21/16 11.28 11.35 10.78 10.78 815,192
12/20/16 11.52 11.73 11.23 11.31 1,020,667
12/19/16 11.63 12.00 11.29 11.34 1,047,355
12/16/16 11.27 11.67 11.25 11.66 1,894,390
12/15/16 11.03 11.51 10.90 11.25 1,160,081
12/14/16 10.98 11.19 10.79 10.98 900,935
12/13/16 11.34 11.54 10.96 11.01 965,594
12/12/16 11.34 11.68 11.19 11.26 892,963
12/09/16 12.09 12.09 11.51 11.53 1,006,017
12/08/16 11.28 11.66 11.05 11.63 1,177,096
12/07/16 11.49 11.565 10.99 11.31 1,666,109
12/06/16 11.70 11.99 11.36 11.88 1,243,549
12/05/16 11.57 11.90 11.27 11.82 921,610
12/02/16 11.21 11.56 11.08 11.37 841,679
12/01/16 11.95 11.96 11.18 11.23 1,446,825
11/30/16 12.14 12.25 11.69 11.81 767,220
11/29/16 11.86 12.22 11.69 12.07 1,655,164
11/28/16 12.91 12.91 11.85 11.86 1,551,076
11/25/16 12.71 13.11 12.45 12.99 780,597
11/23/16 12.22 12.74 12.00 12.65 1,442,175
11/22/16 12.72 12.91 12.44 12.66 1,391,623
11/21/16 12.04 12.71 11.85 12.64 1,500,150
11/18/16 13.06 13.22 12.585 12.83 1,571,488
Recent HALO News
- Halozyme Announces Roche's OCREVUS® SC with ENHANZE® Receives European Commission Approval for Relapsing and Primary Progressive Multiple Sclerosis • PR Newswire (US) • 06/25/2024 05:15:00 AM
- Halozyme Announces argenx Receives FDA Approval for VYVGART® Hytrulo Co-Formulated with ENHANZE® for Chronic Inflammatory Demyelinating Polyneuropathy • PR Newswire (US) • 06/21/2024 09:15:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/18/2024 08:22:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 08:17:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:15:42 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/11/2024 08:40:33 PM
- Halozyme Raises Full Year 2024 Financial Guidance and Updates 5-Year Financial Outlook • PR Newswire (US) • 06/06/2024 12:30:00 PM
- Halozyme Announces Issuance of New European Patent for ENHANZE® Drug Delivery Platform • PR Newswire (US) • 06/05/2024 08:05:00 PM
- Halozyme to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference • PR Newswire (US) • 06/04/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 09:24:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/22/2024 08:08:43 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/21/2024 08:00:43 PM
- Halozyme Announces Bristol Myers Squibb Received Updated Action Date from the U.S. Food and Drug Administration for Subcutaneous Nivolumab Co-Formulated with ENHANZE® • PR Newswire (US) • 05/21/2024 11:15:00 AM
- Halozyme to Participate in Upcoming Investor Conferences • PR Newswire (US) • 05/08/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:09:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:05:55 PM
- HALOZYME REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATING RESULTS • PR Newswire (US) • 05/07/2024 08:01:00 PM
- Mahesh Krishnan Elected to Halozyme's Board of Directors • PR Newswire (US) • 04/25/2024 08:45:00 PM
- Halozyme to Report First Quarter 2024 Financial and Operating Results • PR Newswire (US) • 04/23/2024 12:30:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/04/2024 09:13:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 11:49:54 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/28/2024 09:07:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 10:12:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 10:05:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 10:01:21 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM